Cortechs.ai | Paul Mirabella Joins Cortechs.ai’ Board of Directors

Paul Mirabella Joins Cortechs.ai’ Board of Directors

Healthcare industry veteran to advise on business development and product advancement

SAN DIEGO–Cortechs.ai Inc. announced today that healthcare and diagnostic imaging industry veteran Paul Mirabella has joined the company’s board of directors as its newest member. Paul, who has worked as a senior executive in the healthcare industry for over 40 years, will play an active role in advising Cortechs.ai on matters including, but not limited to, business development strategy as well as product development and enhancement.

“Paul brings a wealth of knowledge from his 40+ years of experience in diagnostic imaging roles at GE Healthcare and his continued private equity consulting for healthcare businesses that is invaluable for the company”

Paul is currently president and chief executive officer (CEO) of Paul J. Mirabella Investments and Consulting, LLC, where he oversees consulting and investments in the medical device industry and medical diagnostics. He is actively involved in developing imaging solutions to reduce radiation exposure as well as artificial intelligence applications in a range of healthcare sectors, with a current focus in neurology. Previously, he served as president and CEO of GE Healthcare Global Diagnostic Imaging Business and the Global Services Business. More recently, he was a key investor in and served as chairman and CEO of Naviscan, Inc., developer of a high resolution, organ-specific PET scanner. He also held four of the original patents in computed tomography.

“I am extremely passionate about working with innovative technology companies to try to improve the outcomes and efficiency of the health care system,” said Paul. “I look forward to building upon the Cortechs.ai current momentum to deploy leading-edge technology providing medical professionals with deeper insights into the diagnosis of neurodegenerative diseases and, most importantly, elevates patient care.”

Paul Mirabella holds a bachelor’s of science in aerospace engineering and applied mechanics from the Polytechnic Institute of Brooklyn (now NYU) and a master’s in mechanical engineering from the University of Central Florida. He has been a guest lecturer on leadership at the University of California, San Diego Rady School of Management.

“Paul brings a wealth of knowledge from his 40+ years of experience in diagnostic imaging roles at GE Healthcare and his continued private equity consulting for healthcare businesses that is invaluable for the company,” said Dr. Chris Airriess, CEO of Cortechs.ai. “We are honored to have Paul on our board of directors and strive to tap his expertise in our continued goal of helping physicians to provide better patient care with the aid of advanced diagnostic imaging solutions.”

Cortechs.ai is attending the Radiological Society of North America’s Annual Meeting this week and has several new initiatives planned for 2020 to broaden their portfolio of quantitative imaging solutions. Paul will join Cortechs.ai in South Hall booth #4055 from 10 a.m. on Monday, December 2, 2019.

About Cortechs.ai
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists and clinical researchers worldwide with a convenient and cost-effective means to quantify brain structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development abnormalities. Please visit cortechs.ai for further information and follow us on TwitterLinkedIn and Facebook.

###

More Resources

09/16/2025

OnQ Prostate for Focal Therapy

Read how OnQ Prostate supports focal therapy by personalizing prostate cancer care for patients while minimizing the risks associated with it.

09/03/2025

Reimbursement Considerations for OnQ Prostate and Category III CPT Codes 0648T & 0649T

Learn how Cat. III CPT codes 0648T and 0649T apply to OnQ™ Prostate, offering guidance for accurate reporting, reimbursement, and building evidence for coverage

09/02/2025

Maximizing the Value of Prostate MRI for the Urologist

Even with expert radiologists or AI models at hand, the challenge remains: how can urologists improve seeing and interpreting cancer?

08/18/2025

Why Bigger Normative Databases Mean Better Brain Imaging

NeuroQuant® 5.2 compares patient brain MRI volumes to over 7,000 healthy scans, giving clinicians clear, percentile-based context for better assessments.

08/07/2025

Navigating Reimbursement for NeuroQuant: Understanding CPT Codes 0865T & 0866T 

Let’s break down the latest category III CPT codes and example clinical use cases that illustrate their value.

07/31/2025

Precision Without the Pressure: Smarter Brain Tumor Monitoring

Learn about NeuroQuant Brain Tumor 2.0 and how it assists clinicians by providing objective quantification and analysis of tumor changes over time.
Scroll to Top